These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 994969)
21. Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial. Atkinson RL; Greenway FL; Bray GA; Dahms WT; Molitch ME; Hamilton K; Rodin J Int J Obes; 1977; 1(2):113-20. PubMed ID: 363629 [TBL] [Abstract][Full Text] [Related]
22. [Effect of mazindol on insulin and glucagon secretion in ventromedial hypothalamic obese rats]. Usami M; Seino Y; Nishi S; Nakahara H; Ikeda M; Matsukura S; Imura H Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):297-303. PubMed ID: 3891549 [TBL] [Abstract][Full Text] [Related]
23. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)]. Mies R Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040 [TBL] [Abstract][Full Text] [Related]
24. Maziniol in the treatment of obesity. Sedgwick JP Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123 [No Abstract] [Full Text] [Related]
25. [Clinical use of mazindol in the treatment of essential obesity]. Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538 [No Abstract] [Full Text] [Related]
26. A multi-centre general practice trial of mazindol in the treatment of obesity. Maclay WP; Wallace MG Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112 [No Abstract] [Full Text] [Related]
27. A multicentre study comparing mazindol and placebo in obese patients. Walker BR; Ballard IM; Gold JA J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596 [TBL] [Abstract][Full Text] [Related]
28. Double-blind trial of mazindol in overweight patients. Heber KR Med J Aust; 1975 Oct; 2(14):566-7. PubMed ID: 1105106 [TBL] [Abstract][Full Text] [Related]
29. Mazindol in the treatment of narcolepsy. Parkes JD; Schachter M Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256 [TBL] [Abstract][Full Text] [Related]
30. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)]. Dolecek R Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197 [No Abstract] [Full Text] [Related]
31. Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity. Lean ME; Borthwick LJ Eur J Clin Pharmacol; 1983; 25(1):41-5. PubMed ID: 6352281 [TBL] [Abstract][Full Text] [Related]
32. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity]. Husmann F Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077 [No Abstract] [Full Text] [Related]
34. A case of Prader-Willi syndrome with long-term mazindol treatment. Inui A; Uemoto M; Takamiya S; Shibuya Y; Baba S; Kasuga M Arch Intern Med; 1997 Feb; 157(4):464. PubMed ID: 9046903 [No Abstract] [Full Text] [Related]
35. Mazindol: its efficacy and mode of action in generating weight loss. Johnson WG; Hughes JR Addict Behav; 1979; 4(3):237-44. PubMed ID: 495247 [No Abstract] [Full Text] [Related]
36. Mazindol in the control of micturition. Woodhouse CR; Tiptaft RC Br J Urol; 1983 Dec; 55(6):636-8. PubMed ID: 6360295 [TBL] [Abstract][Full Text] [Related]
37. A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity. Murphy JE; Donald JF; Molla AL; Crowder D J Int Med Res; 1975; 3(3):202-6. PubMed ID: 162676 [TBL] [Abstract][Full Text] [Related]
38. [Overweight as a therapeutic problem. Experience with the appetite depressant Mazindol]. Linke H Med Welt; 1976 Oct; 27(42):2021-5. PubMed ID: 792620 [No Abstract] [Full Text] [Related]
39. [Treatment of obesity using a new anorectic]. Felt V Vnitr Lek; 1976 Apr; 22(4):371-4. PubMed ID: 1266099 [No Abstract] [Full Text] [Related]